Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study

Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, Alex Antill, Charles M Laymon, Ira Lott, H Diana Rosas, Davneet S Minhas, Weiquan Luo, Shahid Zaman, the Alzheimer’s Biomarker Consortium–Down Syndrome investigators, Mark Mapstone, Elizabeth Head, Florence Lai, Sigan L Hartley, Beau M Ances, Sharon J Krinsky-McHale, Joseph H Lee, Rik Ossenkoppele, Bradley T Christian, Benjamin L Handen, Oskar Hansson.